LTZ Therapeutics, Eli Lilly Collab on Autoimmune Disease Platform
29 Jul 2025 //
BUSINESSWIRE
LTZ Gets FDA IND Clearance For LTZ-301 Myeloid Engager Trial
24 Feb 2025 //
BUSINESSWIRE
LTZ Therapeutics Raises $20M+ Series A For Immunotherapy Pipeline
30 Jul 2024 //
BUSINESSWIRE